Peer Review History
| Original SubmissionAugust 6, 2020 |
|---|
|
PONE-D-20-24477 Mathematical modelling of COVID-19 transmission dynamics in Uganda: implications of complacency and early easing of lockdown PLOS ONE Dear Dr. Ssematimba, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. In particular, please pay attention to the comments by Reviewer #2, on the origin and cause of the 'second wave'. Is this an endogenous event (generated by the model without changing any of its parameters), or is this an exogenous event (caused by factors beyond the model, and typically treated as changes in its parameters)? Please submit your revised manuscript by Nov 22 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Siew Ann Cheong, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service. Whilst you may use any professional scientific editing service of your choice, PLOS has partnered with both American Journal Experts (AJE) and Editage to provide discounted services to PLOS authors. Both organizations have experience helping authors meet PLOS guidelines and can provide language editing, translation, manuscript formatting, and figure formatting to ensure your manuscript meets our submission guidelines. To take advantage of our partnership with AJE, visit the AJE website (http://learn.aje.com/plos/) for a 15% discount off AJE services. To take advantage of our partnership with Editage, visit the Editage website (www.editage.com) and enter referral code PLOSEDIT for a 15% discount off Editage services. If the PLOS editorial team finds any language issues in text that either AJE or Editage has edited, the service provider will re-edit the text for free. Upon resubmission, please provide the following:
[Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Abstract should be structural manner including of subsection like background, methods, results, discussion. The introduction section produces redundant information on COVID-19 background which could be no interest for readers. Rather it is recommended to present related modelling works. Some of works the suggestive a) COVID-19 disease outbreak forecasting of registered and recovered cases after sixty-day lockdown in Italy: A data driven model approach b) A Simulation of a COVID-19 Epidemic Based on a Deterministic SEIR Model c) Modified SEIR and AI prediction of the epidemics trend of COVID-19 in China under public health interventions Clarity of figures is missing. Please enhance the figure aspect ratios Reviewer #2: 1. A standard presentation of this kind of model usually includes derivation of R¬0, the basic reproduction number, equilibrium points, and stability analysis and these should be done mathematically (not through simulation or numerically). Since the focus of this paper is the dynamics that are mainly observed through simulations, the authors can present the mathematical aspect in a very brief way. But this is very important for this kind of modeling. 2. Possibility and impact of a second wave is not clear. I do not understand how this second wave is accommodated in the model. If the authors intend to provide a time line when this second wave might hit, that would be great. However, the objective and presentation can be made much more explicit. This possibility of the second wave is an important issue in this paper. So clear understanding and prediction of time and extent, if possible, should be presented and justified properly. 3. There is no justification of the sample size N=300 in sensitivity analysis. 4. Few minor English corrections are required, like at page 95: Write “since” instead of “from”, etc. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Indranil Mukhopadhyay [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
PONE-D-20-24477R1 Mathematical modeling of COVID-19 transmission dynamics in Uganda: Implications of Complacency and Early Easing of Lockdown PLOS ONE Dear Dr. Ssematimba, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. While it is clear that the manuscript has been improved from the original submission, Reviewer #1 is concerned that the authors did not address specific comments from the first review. We understand that PLOS ONE gives a rather short time to make revisions, but this is just a standard procedure to shorten the time to acceptance and publication. Should you need more time for major revisions, please do not hesitate to make the request. More importantly, because of the COVID-19 situation, Reviewer #2 could no longer assist in the review of the revised manuscript. We are very fortunate to have Reviewer #3 agreeing to help, and to produce a very detailed report on the revised manuscript. Unfortunately, Reviewer #3 has identified further major weaknesses. We advise the authors to take their time to properly address these, before submitting another revision. Please submit your revised manuscript by Jan 07 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Siew Ann Cheong, Ph.D. Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #3: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #3: No ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #3: N/A ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: I wondering that authors did not address the specific comments rasied by reviewer that might considered as not a good practice. Abstract section should has to mention the sub section and we can not assume that readers will automatically understand the authors view. Authors has to address the established data modelling approches in non ease of lockdown and compare it with some spcial case studies like Italy and other european countries (COVID-19 disease outbreak forecasting of registered and recovered cases after sixty-day lockdown in Italy: A data driven model approach). Some areas spell check and grammetical errors has to address Best wishes Reviewer #3: The manuscript utilises a compartmental SEIHR framework to assess the disease dynamics in Uganda, and consider how to tackle future infection possibilities. Current manuscript revisions have already improved the manuscript well. While I feel the work has great potential to advance the understanding of disease dynamics within Uganda, I have substantial concerns with the current model formulation, and the conclusions the authors draw. The primary issue is that the authors attempt to, arguably, do too much with the model, and in doing so each conclusion suffers. I list below my general concerns with the model formulation, and which scenarios are ill-posed for the current model. In general I would urge the authors to restrict their scope, and tweak the model to draw stronger conclusions on a specific research question or two. I feel the model may be best suited with minor adjustment to assessing “The possibility of a second wave infection”, or “The impact of lockdown measures”, while it is currently not an appropriate model for assessing “The impact of magnitude of imported cases” or “Impact of hospital acquired infections”. The Introduction is very strong and suitably frames the work. General Concerns My initial concerns are with the model parameters (Table 1). Many parameters cite the Ugandan data portal (reference [4]) for their values, however I cannot locate these model parameters, nor can I infer them from Ugandan case data. Some parameters are also very far from similar parameter estimates in the literature. For example, a disease-induced mortality rate of 0.001 is far low than estimates elsewhere in the literature. The hospital mortality rate of 0.0001 is even more peculiar. See for example, Baud et al. (2020) “Real estimates of mortality following COVID-19 infection.”. An estimate of 40% asymptotic individuals could hold true, there are multiple studies citing closer to 20% (e.g. Mizumoto et al.), however some more recent studies predict as high as 80% (Day M. “Covid-19: four fifths of cases are asymptomatic, China figures indicate.”). Mentions of such literature should be included. Similarly recovery rate, traced-and-isolated rates ( c ), infectivity in hospitals, need closer scrutiny. All model parameters need more source citations. Parameter q can be removed if it is not used in the model. Moving on to the model itself, a major concern is that individuals who are contacted via test-and-trace are moved to the hospitalisation class (If I understood correctly). This is a major oversight as it will be a significant move of individuals, having a considerable impact on the resulting dynamics, and invalidating any assessment of total hospitalisation numbers (such as figures 2,3,5). This estimation of hospitalised individuals is a major use of these models, and so the assessment must be rigorous. I am also sceptical of the implementation of imported cases. Having this influx of individuals (and I don’t fully understand how these imported cases subsequently leave the population pool in an equal amount) be dependent on the host population size (N) doesn’t make sense. In general, one could perhaps argue for a constant population (in/out) from the infected class, but this formulation is not suitable for then drawing conclusions on the dynamic impact of imported cases from neighbouring countries. It would be better to develop a model of multiple interacting SEIHR networks for this. I would recommend either removing this aspect or better framing this as “the dynamic impact of constant external disease pressure”. I would also be interested in more information on the exact lockdown rules in Uganda to defend the choice of lockdown modelling. The authors have a percentage of the population which is made impossible to become infected due to lockdown. This is appropriate for strict lockdown systems, such as that in Cyprus, where individuals may not leave home without permission, but for systems such as the UK where individuals may leave home freely for essential trips, a far reduced transmission rate may be more appropriate than a flat impossibility of transmission (e.g. Rawson et al. “How and when to end the COVID-19 lockdown”). When the model is introduced (from L102), it is very difficult to interpret the model initially, needing to jump between table 1, figure 1, equations (1)-(5), and brief paragraphs. I would instead urge presenting each equation, one-by-one, and explaining specifically each term (and parameter) in each equation. This may seem excessive, but makes interpreting a model considerably easier. The above issues then raise concern with the interpretation of results: 4.2 – This section seems the most powerful to focus on, and could be expanded by comparing and fitting to Ugandan case data. The current primary result is not particularly useful or enlightening, less people in lockdown = more people infected. More interesting would be to then expand this to ask “how strict does a lockdown need to be to not exceed hospital capacity?” “When should a lockdown be ended?” etc. The current metric of hospitalisations is incorrect due to the above test-and-trace classification issues. 4.3 – I currently don’t think this model formulation is powerful enough to answer questions on the impact of imported cases. The result that “COVID remains endemic” is due precisely to the model formulation. The constant influx of infection from these cases ensures an endemic outbreak. If the authors wanted to investigate the impact of imported cases then this influx should be variable. Then the model can answer questions such as “When should imports from country A be allowed based on their case rates?”. 4.4 – This section will be insightful, however the above concerns on model formulation and parameterisation need to be addressed first. 4.5 – I don’t think the model is suitable for assessing the impact of hospital-acquired infections currently. This is an interesting dynamic, but would benefit from a more bespoke model, with separate healthcare compartmentalisations. The current hopsitalisation framework (see above) invalidates the current results. 4.6 – I’m not sure the text here actually correlates with the sensitivity analysis of Figure 6. The text states that a, e, b, and g are most influential. However Figure 6 seems to infer that a and lambda are the most impactful, and the others have minor impact. Certainly g and e seem of low impact. Also, the bins of Figure 6 should be marked with their respective parameters. The current colour scheme is hard to distinguish. Minor Comments: L51/L52 – “measures reduced the susceptible population to about 10%”, this is important, is there a citation for this? L129 – Does this mean that asymptomatic individuals are hospitalised? I assume this is due to the test-and-trace, this needs to be changed. L266 – What is meant by undetected infectious here? Mentioned specifically which model variable you mean when referenced (e.g. I/E) The model is good and I think it is of critical importance to investigate country-specific disease trajectories, the scope and details of the model just need to be refined. I look forward to seeing a more refined revision and believe it will make a strong contribution when finished. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #3: Yes: Thomas Rawson [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
PONE-D-20-24477R2 Mathematical modeling of COVID-19 transmission dynamics in Uganda: Implications of Complacency and Early Easing of Lockdown PLOS ONE Dear Dr. Ssematimba, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. These issues are minor, and after they are addressed I expect we will be able to accept the manuscript for publication. Please submit your revised manuscript by Feb 18 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Siew Ann Cheong, Ph.D. Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #3: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #3: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Authors are precisly addressed the comments by adding comprehensive discussion in article. I recommend to accept the article in present form Reviewer #3: See attached document for full comments. In summary, the final revision needed is just some final justification and explanation of some model parameters in the manuscript. Mortality rate will likely need to be changed and, as such, figure plots may need to be re-done. " SUMMARY The revisions made address almost all of my points very well. There is only one point that needs addressing before I can finally recommend for publication, and that is regarding the model parameter values again. This work will be extremely useful in the coming years I believe for investigating the impact of different mitigation strategies, and as such it is important to make sure that these parameter values are well cited and explained for future readers to understand the measures unique to Uganda. Essentially I would just want to see some more information for those parameters that cite reference [4]. Naturally, some of these parameters will be deeply uncertain, and so “back-of-the-envelope” estimates will need to be used. There is nothing wrong with this, however I would want to see exactly how these values were reached. As this could involve a lot of text, I would perhaps recommend moving these calculations to a separate appendix or supplementary info page. Also, where specific press-releases or ministerial briefings are used, these specific briefings should be cited, such as the ones that the authors linked to me in the above comment regarding influx from other countries / lockdown amounts. In short, a lot of the justification given to me in responses by the authors should be included for all readers! Really the main sticking point here is still the mortality rate. These estimates were based on old data that is clearly now not an accurate representation of the true mortality rate to my eyes. Indeed, based on today’s case data the total mortality rate is 0.007 in Uganda for confirmed cases. The current parameter value used is likely to really affect the results shown, which is important given some of the findings regarding hospital capacity. I think these really need to be re-run with an improved mortality rate, unless my understanding is incorrect? Once this is addressed I will be happy to recommend for publication. A minor point, I think it would be extremely helpful for reviewers if a paragraph was included in the Introduction that outlines the specific, extreme, protocols used in Uganda. This motivates the work extremely well, showing why bespoke modelling frameworks are needed. Finally, L295 – “Even more worrying is the fact that the endemic level would higher at bigger levels of susceptibility” – I think there’s a typo here, I’m a bit confused about what is trying to be said with this sentence? " ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #3: Yes: Thomas Rawson [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 3 |
|
Mathematical modeling of COVID-19 transmission dynamics in Uganda: Implications of Complacency and Early Easing of Lockdown PONE-D-20-24477R3 Dear Dr. Ssematimba, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Siew Ann Cheong, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-20-24477R3 Mathematical modeling of COVID-19 transmission dynamics in Uganda: implications of complacency and early easing of lockdown Dear Dr. Ssematimba: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Siew Ann Cheong Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .